Lenka Borská, Zdenek Fiala, Jindra Smejkalová, Kvetoslava Hamáková, Jan Kremlácek
{"title":"Goeckerman治疗银屑病的基因毒性风险。试点研究——子女)。","authors":"Lenka Borská, Zdenek Fiala, Jindra Smejkalová, Kvetoslava Hamáková, Jan Kremlácek","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Goeckerman's therapy of psoriasis includes combined exposure to therapeutic tar and UV-B radiation. In a pilot study of (12 children) a level of genotoxic risk of the therapy was evaluated by chromosomal aberration of peripheral lymphocytes. Results of the pilot study suggest possible genotoxic risk of the therapy.</p>","PeriodicalId":79548,"journal":{"name":"Acta medica (Hradec Kralove). Supplementum","volume":"47 1","pages":"19-21"},"PeriodicalIF":0.0000,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Genotoxic risk of Goeckerman's therapy of psoriasis. Pilot study--children].\",\"authors\":\"Lenka Borská, Zdenek Fiala, Jindra Smejkalová, Kvetoslava Hamáková, Jan Kremlácek\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Goeckerman's therapy of psoriasis includes combined exposure to therapeutic tar and UV-B radiation. In a pilot study of (12 children) a level of genotoxic risk of the therapy was evaluated by chromosomal aberration of peripheral lymphocytes. Results of the pilot study suggest possible genotoxic risk of the therapy.</p>\",\"PeriodicalId\":79548,\"journal\":{\"name\":\"Acta medica (Hradec Kralove). Supplementum\",\"volume\":\"47 1\",\"pages\":\"19-21\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2004-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta medica (Hradec Kralove). Supplementum\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta medica (Hradec Kralove). Supplementum","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Genotoxic risk of Goeckerman's therapy of psoriasis. Pilot study--children].
Goeckerman's therapy of psoriasis includes combined exposure to therapeutic tar and UV-B radiation. In a pilot study of (12 children) a level of genotoxic risk of the therapy was evaluated by chromosomal aberration of peripheral lymphocytes. Results of the pilot study suggest possible genotoxic risk of the therapy.